Home / Pharma Healthcare / Global Budesonide Market by Manufacturers, Regions, Type and Application, Forecast to 2021

Global Budesonide Market by Manufacturers, Regions, Type and Application, Forecast to 2021

  • Id : RNR-43071
  • Category : Pharma Healthcare
  • Publish Date : Nov-16
  • Pages : 117
  • Format : PDF
License Type

Description
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and nasal spray.The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The nasal spray is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis.

Scope of the Report:
This report focuses on the Budesonide in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
    AstraZeneca
    Cosmo Pharmaceuticals
    Teva
    Mylan
    Sandoz
    Dr. Falk Pharma
    Chiesi Farmaceutici S.p.A
    Orion Corporation
    Cipla
    Synmosa Biopharma Corporation
    Lunan Better Pharmaceutical
    Shanghai Sine Promod Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
    Nasal spray
    Inhaler
    Pill&Rectal forms

Market Segment by Applications, can be divided into
    Respiratory disease treatment
    Nose disease treatment
    Inflammatory bowel disease treatment

There are 13 Chapters to deeply display the global Budesonide market.

Chapter 1, to describe Budesonide Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Budesonide, with sales, revenue, and price of Budesonide, in 2015 and 2016;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2015 and 2016;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Budesonide, for each region, from 2011 to 2016;

Chapter 5, 6, 7 and 8, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 9 and 10, to show the market by type and application, with sales market share and growth rate by type, application, from 2011 to 2016;



Chapter 12 and 13, to describe Budesonide sales channel, distributors, traders, dealers, appendix and data source.